Korean Pharma Calls For New Policy ‘Control Tower’, More Support
Executive Summary
Amid the recent ousting of President Park Geun-hye amid corruption allegations and a new presidential election only weeks away, the South Korean pharma industry is quickening its calls for policy support from the next administration by recommending a variety of changes.